Clinical Research Directory
Browse clinical research sites, groups, and studies.
Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
Sponsor: Xiangtan Central Hospital
Summary
The primary objective of this study is to investigate the hemoglobin change and association between hemoglobin change and readmissions due to heart failure, and all-cause death in patients with heart failure treated with dapagliflozin or placebo.
Official title: A Prospective, Randomized, Double-blind, Multicenter Study on the Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
1990
Start Date
2021-08-06
Completion Date
2026-01-01
Last Updated
2024-07-01
Healthy Volunteers
No
Conditions
Interventions
Dapagliflozin
Participants will receive dapagliflozin 10 mg once daily
Placebo
Participants will receive placebo 10 mg once daily
Locations (1)
Xiangtan Central Hospital
Xiangtan, Hunan, China